DOXIMITY INC-CLASS A (DOCS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:DOCS - US26622P1075 - Common Stock
39.28 USD
-1.12 (-2.77%)
DOCS gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 34 industry peers in the Health Care Technology industry. Both the health and profitability get an excellent rating, making DOCS a very profitable company, without any liquidiy or solvency issues. DOCS is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! With these ratings, DOCS could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
- DOCS had positive earnings in the past year.
- In the past year DOCS had a positive cash flow from operations.
- DOCS had positive earnings in each of the past 5 years.
- In the past 5 years DOCS always reported a positive cash flow from operatings.
1.2 Ratios
- The Return On Assets of DOCS (20.13%) is better than 100.00% of its industry peers.
- The Return On Equity of DOCS (23.10%) is better than 100.00% of its industry peers.
- With an excellent Return On Invested Capital value of 18.16%, DOCS belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for DOCS is significantly above the industry average of 6.63%.
- The 3 year average ROIC (14.17%) for DOCS is below the current ROIC(18.16%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.13% | ||
| ROE | 23.1% | ||
| ROIC | 18.16% |
ROA(3y)13.75%
ROA(5y)12.65%
ROE(3y)16.22%
ROE(5y)15.68%
ROIC(3y)14.17%
ROIC(5y)16.48%
1.3 Margins
- DOCS has a better Profit Margin (40.72%) than 100.00% of its industry peers.
- In the last couple of years the Profit Margin of DOCS has grown nicely.
- With an excellent Operating Margin value of 39.72%, DOCS belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
- DOCS's Operating Margin has improved in the last couple of years.
- DOCS has a better Gross Margin (90.20%) than 97.06% of its industry peers.
- In the last couple of years the Gross Margin of DOCS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 39.72% | ||
| PM (TTM) | 40.72% | ||
| GM | 90.2% |
OM growth 3Y6.88%
OM growth 5Y16.16%
PM growth 3Y0.28%
PM growth 5Y33.35%
GM growth 3Y0.66%
GM growth 5Y0.68%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so DOCS is creating value.
- DOCS has more shares outstanding than it did 1 year ago.
- DOCS has more shares outstanding than it did 5 years ago.
- There is no outstanding debt for DOCS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 30.47 indicates that DOCS is not in any danger for bankruptcy at the moment.
- DOCS's Altman-Z score of 30.47 is amongst the best of the industry. DOCS outperforms 100.00% of its industry peers.
- DOCS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 30.47 |
ROIC/WACC1.92
WACC9.44%
2.3 Liquidity
- A Current Ratio of 7.79 indicates that DOCS has no problem at all paying its short term obligations.
- With an excellent Current ratio value of 7.79, DOCS belongs to the best of the industry, outperforming 94.12% of the companies in the same industry.
- A Quick Ratio of 7.79 indicates that DOCS has no problem at all paying its short term obligations.
- The Quick ratio of DOCS (7.79) is better than 94.12% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.79 | ||
| Quick Ratio | 7.79 |
3. Growth
3.1 Past
- DOCS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 46.43%, which is quite impressive.
- The Earnings Per Share has been growing by 79.21% on average over the past years. This is a very strong growth
- The Revenue has grown by 20.21% in the past year. This is a very strong growth!
- The Revenue has been growing by 37.42% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)46.43%
EPS 3Y20.79%
EPS 5Y79.21%
EPS Q2Q%50%
Revenue 1Y (TTM)20.21%
Revenue growth 3Y18.42%
Revenue growth 5Y37.42%
Sales Q2Q%23.16%
3.2 Future
- DOCS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.75% yearly.
- The Revenue is expected to grow by 11.49% on average over the next years. This is quite good.
EPS Next Y14.19%
EPS Next 2Y11.57%
EPS Next 3Y11.76%
EPS Next 5Y14.75%
Revenue Next Year14.06%
Revenue Next 2Y12.59%
Revenue Next 3Y12.01%
Revenue Next 5Y11.49%
3.3 Evolution
- Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 23.95 indicates a rather expensive valuation of DOCS.
- Compared to the rest of the industry, the Price/Earnings ratio of DOCS indicates a somewhat cheap valuation: DOCS is cheaper than 79.41% of the companies listed in the same industry.
- The average S&P500 Price/Earnings ratio is at 27.25. DOCS is around the same levels.
- Based on the Price/Forward Earnings ratio of 22.38, the valuation of DOCS can be described as rather expensive.
- Based on the Price/Forward Earnings ratio, DOCS is valued a bit cheaper than 76.47% of the companies in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 25.98, DOCS is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.95 | ||
| Fwd PE | 22.38 |
4.2 Price Multiples
- DOCS's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. DOCS is cheaper than 64.71% of the companies in the same industry.
- DOCS's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. DOCS is cheaper than 70.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.69 | ||
| EV/EBITDA | 23.28 |
4.3 Compensation for Growth
- DOCS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The excellent profitability rating of DOCS may justify a higher PE ratio.
PEG (NY)1.69
PEG (5Y)0.3
EPS Next 2Y11.57%
EPS Next 3Y11.76%
5. Dividend
5.1 Amount
- DOCS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
DOXIMITY INC-CLASS A / DOCS FAQ
What is the fundamental rating for DOCS stock?
ChartMill assigns a fundamental rating of 7 / 10 to DOCS.
What is the valuation status for DOCS stock?
ChartMill assigns a valuation rating of 4 / 10 to DOXIMITY INC-CLASS A (DOCS). This can be considered as Fairly Valued.
How profitable is DOXIMITY INC-CLASS A (DOCS) stock?
DOXIMITY INC-CLASS A (DOCS) has a profitability rating of 9 / 10.
What are the PE and PB ratios of DOXIMITY INC-CLASS A (DOCS) stock?
The Price/Earnings (PE) ratio for DOXIMITY INC-CLASS A (DOCS) is 23.95 and the Price/Book (PB) ratio is 6.75.
What is the earnings growth outlook for DOXIMITY INC-CLASS A?
The Earnings per Share (EPS) of DOXIMITY INC-CLASS A (DOCS) is expected to grow by 14.19% in the next year.